Les CFD sont des instruments complexes et sont accompagnés d’un risque élevé de pertes financières rapides en raison de l’effet de levier. 74 % des comptes d’investisseurs particuliers perdent de l’argent en tradant des CFD avec ce fournisseur. Vous devez déterminer si vous comprenez comment fonctionnent les CFD et si vous pouvez vous permettre de courir le risque élevé de perdre votre argent.

Close

 Graphique en direct de JnJ

Principes de base des instruments

Weekly Search
Weekly
Daily
Date Fermer Changes % Variation Ouvrir un compte Haut Bas

Actualités

Webhose 2025 Apr 02, 20:15

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers de l'exercice 2024

Johnson & Johnson
Webhose 2025 Mar 17, 20:15

NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu'à mi-2026

Johnson & Johnson

Dernières nouvelles

Closing 2024
2024 Dec 26, 17:00

Semaine à venir : Clôture de l’année 2024 et premières données économiques de 2025

UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Semaine à venir : Dernière semaine complète de 2024 sur les marchés financiers

Le Forex Indices
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Semaine à venir : Les taux d'intérêt américains et l'inflation en Europe déterminent l'orientation des marchés

Indices Le Forex
Dyogenes Diniz 2024 Dec 05, 16:00

Semaine à venir : L'inflation et les taux d'intérêt vont secouer les marchés cette semaine

Le Forex Indices
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Semaine à venir :  L'emploi aux États-Unis devrait influencer le sentiment des marchés cette semaine.

Le Forex Indices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Semaine à venir : L'inflation de la zone euro devrait confirmer une réduction des taux de la BCE en décembre

Le Forex Indices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Semaine à venir : La hausse de la tech table sur les résultats de Nvidia

Le Forex Indices
Markets.com Support Team 2024 Nov 07, 16:00

Semaine à venir : « Trump trade », données sur l'inflation, résultats de Disney

Le Forex Indices

Info

Spread

0.95

Spread (%)

0.6419 %

Effet de levier

1:2

Intérêt au jour le jour à l’achat

-0.0597 %

Intérêt au jour le jour à la vente

-0.0292 %

Devise

USD

Horaires de Trading

Markets closed

Vendredi

13:31 - 19:59

Lundi

13:31-19:59

Mardi

13:31-19:59

Mercredi

13:31-19:59

Jeudi

13:31-19:59

Analyse et statistiques

Ouvrir un compte

---

Fermeture précédente

---

Plus haut/plus bas des 52 dernières semaines

--- – ---

Capitalisation boursière

365646544896

Actions en circulation

2409850112

Date de rapport d'activité (suivante)

2001-06-13

Rendement des div

2025-03-04

Date de détachement du dividende

2025-02-18

Le taux de dividende annuel à terme 

4.96

Le rendement de dividende annuel à terme

0.0327

EPS

5.8

En savoir plus sur cet instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Instruments connexes

Actif
Vendre
Acheter
% Variation
Instruments connexes
Trustpilot
SettingsRequest history38.1.18PHP Version20.9msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
21.13ms
peak_memory
4MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
0 of 0
array:14 [ "cookie" => array:1 [ 0 => "mktv4_ip_override=fr; mktloc=eyJpdiI6ImVEUzB2Z3BuT1lHL2wyMEtuTTNlWnc9PSIsInZhbHVlIjoiM25sRk9EWjZSM09CNkpKK3ZDVHVOc0ZyUDBKNEEzbXB0a0pLeVgxd2FXckFsYk1QV21ocGxWSFE2SEVsRVlYVSIsIm1hYyI6IjAzZGNlZDg2NWYwNzNmNmQ1MzcxY2RhYTRjMGVjOTkyMmRkODAyZWE1NzczMDYzNDYxNDNiNDU2OGExOTBiZjkiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fhi%252Finstrument%252Fewt%252F; intent_instrument=ewt; XSRF-TOKEN=eyJpdiI6IjFaT1FFVnYyYUM1Znh6cDZPZkNvdWc9PSIsInZhbHVlIjoiTUlDQk02QUdaWTViK05kSmtsRkxXaHJHNWdFMUk3R2ZLTlpGMzNqbEhpdldyTzdMVXM1bFlhK3lyS3V6MGxpNkdNVnhKRm4xblpOVXFSYWhiWkZVWE0zcjdQbFZBOWJKWFpiS2lCL3I2Rmtrc3EyZVAyczFlSEtLdjBZRXlwaVEiLCJtYWMiOiJlODg3YTJlYTM5ZTk4NmNjZWUwZDA5MGQ1MTVhNjk1ZTY5ZTFhYWU2MmMwOWQ5MTYwYjNiMzY5MGZjNTFlYTJkIiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6IkFlcWhFaGJKMWMyRDUydkNKVDAyVkE9PSIsInZhbHVlIjoiNHc5V2xLRldEVzJ3QzFHZ0Q4L2VNcGJHMU9OTW9JYW8zd1drQ3ZRTGF5YmgybHFrci9jakRUNmw1bjNVWXJlWFVQUWhCdGlwRGRtY1NFamo5dGp2SWwyVDIrL0h4cHE0eTRVSlZXU3ZXbG1TNmJUbTRMWWVmcVFqYTBnS1Blc00iLCJtYWMiOiIyNTdiZTkzNTdjNjMxMTZjOTJjNjk4NDk4YmU3YTI1NDBlNzMwMGJjMmQxZGQ2NDUyNTJmYjY2ZjRlMGY0ZTU3IiwidGFnIjoiIn0%3D; firstURL=https://web-qa.staging.markets.com/fr/instrument/mdy/; lastURL=https://web-qa.staging.markets.com/fr/instrument/mdy/mktv4_ip_override=fr; mktloc=eyJpdiI6ImVEUzB2Z3BuT1lHL2wyMEtuTTNlWnc9PSIsInZhbHVlIjoiM25sRk9EWjZSM09CNkpKK3ZDVHVOc0ZyUDBKNEEzbXB0a0pLeVgxd2FXckFsYk1QV21ocGxWSFE" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate, br, zstd" ] "sec-fetch-dest" => array:1 [ 0 => "empty" ] "sec-fetch-mode" => array:1 [ 0 => "cors" ] "sec-fetch-site" => array:1 [ 0 => "same-origin" ] "accept" => array:1 [ 0 => "*/*" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "web-qa.staging.markets.com" ] ]
request_cookies
0 of 0
array:8 [ "mktv4_ip_override" => null "mktloc" => "us,us" "intent_group" => null "intent_instrument" => null "XSRF-TOKEN" => "K1kSL2onSypc1qQbLOcTBZPWL9yckQmWm4kPQJuC" "laravel_session" => "QYh0RqQL0zPdhuRdd5oD94KJqrJYHSRWx5y6L6fO" "firstURL" => null "lastURL" => null ]
response_headers
0 of 0
array:3 [ "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 15 Apr 2025 01:09:58 GMT" ] "content-type" => array:1 [ 0 => "application/json" ] ]
session_attributes
0 of 0
array:4 [ "_token" => "K1kSL2onSypc1qQbLOcTBZPWL9yckQmWm4kPQJuC" "PHPDEBUGBAR_STACK_DATA" => [] "_previous" => array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ] "_flash" => array:2 [ "old" => [] "new" => [] ] ]
    • Booting (11.95ms)time
    • Application (8.94ms)time
    • Routing (475μs)
    • 1 x Booting (57.16%)
      11.95ms
      1 x Application (42.78%)
      8.94ms
      1 x Routing (2.27%)
      475μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              K1kSL2onSypc1qQbLOcTBZPWL9yckQmWm4kPQJuC
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-15 01:09:56GET/fr/instrument/jnj/568
              #22025-04-15 01:09:58GET/csrf/ (ajax)
              #32025-04-15 01:09:58GET/params/ (ajax)